Loading company…
viDA Therapeutics develops therapeutics that target granzymes, serine proteases linked to inflammatory and immune diseases.
Headquartered in Vancouver, Canada, viDA Therapeutics was founded by Alistair Duncan and David Granville. Its inhibitors target granzymes for immune-mediated skin disease, chronic ocular conditions and other immune disorders, and it earns revenue through pharma licensing, milestone payments and royalties. The company has raised USD 1.8 mn in total, with its latest round in July 2013 led by BDC Capital and private investors, across 3 deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in